Abiraterone With Low-Dose Prednisone in Patients With Prostate Cancer
June 22nd 2015Joseph F. Renzulli, II, MD, FACS, assistant professor of Surgery, (Urology), Alpert Medical School, Brown University, discusses a phase II study that examined the use of abiraterone acetate with low-dose prednisone in patients with prostate cancer.